Organization Profile

You just read:

Oncolytics Biotech® Inc. Announces Filing for Orphan Drug Designation with the U.S. FDA for High Grade Gliomas in Pediatric Patients

News provided by

Oncolytics Biotech Inc.

Feb 09, 2015, 06:30 ET